Morounfolu Olugbosi

Morounfolu Olugbosi, MD, MSc., is an accomplished medical professional with extensive experience in clinical development and medical affairs, particularly in the field of vaccines and tuberculosis treatment. As the Senior Director of Clinical Development at TB Alliance since August 2017, Morounfolu Olugbosi oversees clinical trials for novel TB drugs in endemic regions and leads the South Africa office. Previously, at GSK from March 2015 to July 2017, Morounfolu Olugbosi served as Vaccines Medical Lead for South and Southern Africa and managed clinical research related to vaccine safety and efficacy. Prior positions included roles at Novartis Vaccines, where Morounfolu Olugbosi managed various clinical studies across North America and the Middle East & Africa. Morounfolu Olugbosi holds a Master's in Vaccinology and Pharmaceutical Clinical Development from the University of Siena and has contributed to significant public health initiatives, including HIV seroprevalence surveys in Nigeria.